Elevance Health Inc (ELV) — Who Owns This Stock? 13F Breakdown (Q2 2026)

ELV ranks #216 out of 37696 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

ELV is a top-conviction position for Baupost Group Llc/ma — at 9.1% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.

The largest dollar stake in ELV belongs to BlackRock, Inc., but the position matters far more to Baupost Group Llc/ma, who has 9.1% of their own portfolio riding on it — a reminder that the biggest holder by size and the holder with the biggest bet aren't always the same fund.

Atria Investments, Inc has added to its ELV position for two straight quarters, increasing it by $9.9M to reach $15.0M today.

TD Waterhouse Canada Inc. has trimmed its ELV position for two straight quarters, cutting it by $4.2M while still holding $6.5M.

ELV is down 0% today, but institutions show net buying of $31.5B this quarter — a divergence between today's price move and the underlying institutional flow.

ELV posted net income of $5.0B over the trailing twelve months.

• Profitable — net income of $5.0B over the trailing twelve months
• Revenue grew 6.3% year over year
• Net income declined year over year, from $5.4B to $5.0B
• Generated $4.3B in positive operating cash flow
• Current ratio of 1.54x — enough short-term assets to cover short-term liabilities
• Liabilities run 1.77x equity — within a conventional range